Autologous bone marrow transplantation in non-Hodgkin's lymphoma patients: Effect of a brief course of G-CSF on harvest and recovery

Bone Marrow Transplantation

Volumn 24, Issue 7, 1999, Pages 757-761

  Damiani, D ^a   Grimaz, S ^a   Infanti, L ^a   Sperotto, A ^a   Silvestri, F ^a   Geromin, A ^a   Cerno, M ^a   Savignano, C ^a   Michieli, M ^a   Skert, C ^a   Fanin, R ^a   Baccarani, M ^a  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

ABMT; Bone marrow; Engraftment; G CSF

Indexed keywords

ACICLOVIR; AMPHOTERICIN; CARMUSTINE; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; ITRACONAZOLE; NYSTATIN; PARACETAMOL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TEICOPLANIN;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BACTERIAL INFECTION; BLOOD CELL COUNT; BLOOD VOLUME; BONE PAIN; COLONY FORMING UNIT GM; CONTROLLED STUDY; FEMALE; HOSPITALIZATION; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MYCOSIS; NEUTROPHIL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; STEADY STATE; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE; VIRUS INFECTION;

EID: 0032872462     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701979     Document Type: Article

References (25)

1. Demuynck H, Delforge M, Zachèe P et al. An update on peripheral blood progenitor cell transplantation. Ann Hematol 1995; 71: 29-33.
2. To LB, Haylock DN, Simmons PJ, Juttner CA. The biology and clinical uses of blood stem cells. Blood 1997; 89: 2233-2258.
3. Mahè B, Milpied N, Hermouet S et al. G-CSF alone mobilized sufficient peripheral blood CD34+ cells for positive selection in newly diagnosed patients with myeloma and lymphoma. Br J Haematol 1996; 92: 263-268.
4. Bensinger W, Singer J, Appelbaum F et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of granulocyte stimulating factor. Blood 1993; 81: 3158-3163.
5. To LB, Sheppard KM, Haylock DN et al. Single high dose of cyclophosphamide enables the collection of high numbers of hematopoietic stem cells in the peripheral blood. Exp Hematol 1990; 18: 442-447.
6. Sheridan SP, Begley CG, Juttner CA et al. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high dose chemotherapy. Lancet 1992; 339: 640-644.
7. Chao NJ, Schriber JR, Grimes K et al. Granulocyte colony-stimulating factor 'mobilised' peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high dose chemotherapy. Blood 1993; 81: 2031-2035.
8. Schmitz N, Linch DC, Dreger P et al. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 1996; 347: 353-357.
9. Beyer J, Schwella N, Zigsen J et al. Hematopoietic rescue after high dose chemotherapy using autologous peripheralblood progenitor cells or bone marrow: a randomized comparison. J Clin Oncol 1995; 3: 1328-1335.
10. Janssen WE, Smilee RC, Elfenbein GJ. A prospective randomized trial comparing blood- and marrow-derived stem cells for hematopoietic replacement following high-dose chemotherapy. J Hematother 1995; 4: 139-140.
11. Lowenthal RM, Sullivan SA, Parker N, Mardsen KA. G-CSF-primed bone marrow cells for autologous transplantation. Lancet 1996; 347: 1125.
12. Dicke KA, Hood DL, Arneson M. Effects of short-term in vivo administration of G-CSF on bone marrow prior to harvesting. Exp Hematol 1997; 25: 34-38.
13. Damiani D, Fanin R, Silvestri F et al. Randomized trial of autologous filgrastim-primed bone marrow transplantation versus filgrastim-mobilized peripheral blood stem cell transplantation in lymphoma patients. Blood 1997; 90: 36-42.
14. Infanti L, Silvestri F, Fanin R et al. The F-MACHOP regimen in the treatment of aggressive non-Hodgkin's lymphomas: a single centre experience in 72 patients. Haematologica 1996; 81: 521-528.
15. Sutherland DR, Anderson I, Keeney M et al. The ISHAGE guidelines for CD34+ cell determination for flow cytometry. J Hematother 1996; 5: 213-226.
16. Johnsen HE, Hansen PB, Plesner T et al. Increased yield of myeloid progenitor cells in bone marrow harvested for autologous transplantation by pretreatment with recombinant human granulocyte-colony stimulating factor. Bone Marrow Transplant 1992; 10: 229-234.
17. Hansen PB, Knudsen H, Gaarsdal E et al. Short-term in vivo priming of bone marrow hematopoiesis with rhG-CSF, rhGMCSF or rhIL-3 before marrow harvest expands myelopoiesis but does not improve engraftment capability. Bone Marrow Transplant 1995; 16: 373-379.
18. Ciavarella D. Hematopoietic stem cell processing and storage. In: Goldstein J (ed.). Biotechnology of Blood. Butterworth-Heinemann: Boston, MA, 1991, pp 317-349.
19. Lyman SD, Jacobsen EW. C-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood 1998; 91: 1101-1134.
20. Steen R, Tjonnfjord GE, Gunnes Groseth LA et al. Efflux of CD34+ cells from bone marrow to the peripheral blood is selective in steady-state hematopoiesis and during G-CSF administration, J Hematother 1997; 6: 563-573.
21. Faucher C, le Corroller AG, Blaise D et al. Comparison of G-CSF-primed peripheral blood progenitor cells and bone marrow auto transplantation: clinical assessment and cost effectiveness. Bone Marrow Transplant 1994; 14: 895-901.
22. Hartmann O, le Corroller AG, Blaise D et al. Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A randomized, controlled trial. Ann Intern Med 1997; 126: 600-607.
23. Smith TJ, Hillner BE, Schmitz N et al. Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma. J Clin Oncol 1997; 15: 5-10.
24. Storek J, Gooley T, Sioadak M et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood 1997; 90: 4705-4709.
25. Scott MA, Gandhi MK, Jestice HK et al. A trend towards an increased incidence of chronic graft-versus-host disease following allogeneic peripheral blood progenitor cell transplantation: a case controlled study. Bone Marrow Transplant 1998; 22: 273-276.